Haemophilus Influenzae Type B Strain 20752

Haemophilus Influenzae Type B Strain 20752 Uses, Dosage, Side Effects, Food Interaction and all others data.

Haemophilus influenzae type b strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen is an active immunization as a booster dose given intramuscularly to pediatric patients who have received a primary series with a Haemophilus b Conjugate Vaccine that is licensed for primarly immunization. The vaccine contains Haemophilus b capsular polysaccharide (polyribosyl-ribitol-phosphate [PRP]), which is a high molecular weight polymer prepared from the Haemophilus influenzae type b strain 20,752. These are heat inactivated and purified.

Table Of contents

• Haemophilus Influenzae Type B Strain 20752
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Haemophilus Influenzae Type B Strain 20752
Generic	Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen
Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen Other Names	Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine
Type
Groups	Approved, Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Indicated for active immunization in pediatric patients 15 months through 4 years of age as a booster dose for the prevention of invasive disease caused by Haemophilus influenzae type b.

Haemophilus Influenzae Type B Strain 20752 is also used to associated treatment for these conditions: Haemophilus Influenzae Infections, Tetanus

Innovators Monograph

You find simplified version here Haemophilus Influenzae Type B Strain 20752